Soergel David
Chief Medical Officer
Soergel David has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jun 1, 2026.
On the most recent filing, Soergel David is listed as Chief Medical Officer at MADRIGAL PHARMACEUTICALS, INC. Inside the rolling window, Soergel David reported no open-market purchases and 2 open-market sales totaling $952K in MDGL. The largest disclosed transaction in the window is a sale of 1,042 MDGL shares on Jun 1, 2026, worth $517K.
Companies traded
Other insiders at MDGL
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$952K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Soergel David made?
Soergel David has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Soergel David trade?
Soergel David has filed SEC Form 4 disclosures for 1 company, including MDGL.
When was Soergel David's most recent SEC Form 4 filing?
Soergel David's most recent SEC Form 4 filing on Tracefour is dated Jun 1, 2026.
What is Soergel David's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Soergel David is listed as Chief Medical Officer.
What is Soergel David's total buy and sell value in the current window?
Inside the rolling retention window, Soergel David bought $0 and sold $952K based on SEC Form 4 filings.
What was Soergel David's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,042 MDGL shares on 2026-06-01, worth $517K, per SEC Form 4 filings.